Ariad to add two activist-backed directors to board

[Reuters] – Ariad Pharmaceuticals Inc, which has been struggling with safety concerns involving its only approved drug, said it agreed to add two directors backed by its second-largest investor Sarissa Capital Management to its board. Ariad shares rose n more

View todays social media effects on ARIA

View the latest stocks trending across Twitter. Click to view dashboard

See who ARIAD is hiring next, click here to view